Clinical Trial

Effect of vitk2 on Atopic Dermatitis Pediatrics Patients

Name: Effect of vitk2 on Atopic Dermatitis Pediatrics Patients — clinical trial record (NCT07574242)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

investigate the effectiveness and safety of adding vitamin K2 at a dose of 45 mg/day for 12 weeks to conventional therapy for paediatric patients with moderate to severe atopic dermatitis according to SCORAD score

Trial Details

NCT Number	NCT07574242
Lead Sponsor	October 6 University
Conditions	Atopic Dermatitis
Enrollment	100 participants
Start Date	2024-08-03
Primary Completion	2025-05-05 (estimated)
Study Completion	2025-05-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-07